The latest issue of The Joint Commission’s Ambulatory Advisor includes an article providing guidance for surgery centers to meet the requirements for the use of multi-dose vials. The Joint Commission ...
Cemsidomide demonstrated a 50% ORR at 100 μg, with one patient achieving a complete response and no detectable disease. The phase 1 study's dose-escalation phase is complete, and the 100 μg dose is ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results